Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection.
Kuijper LH, Kreher C, Elias G, Claireaux M, Kerster G, Bos AV, Duurland MC, Konijn VAL, Paul AGA, de Jong N, de Jongh R, Steenhuis M, Garcia-Vallejo JJ, van Gils MJ, Kuijpers TW, Eftimov F, Rispens T, van der Schoot CE, van Ham SM, Ten Brinke A. Kuijper LH, et al. Among authors: rispens t. Front Immunol. 2024 Dec 17;15:1505719. doi: 10.3389/fimmu.2024.1505719. eCollection 2024. Front Immunol. 2024. PMID: 39742271 Free PMC article.
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients.
Toorop AA, Wessels MH, Boonkamp L, Gelissen LM, Hoitsma E, Zeinstra EM, van Rooij LC, van Munster CE, Vennegoor A, Mostert JP, Wokke BH, Kalkers NF, Hoogervorst EL, van Eijk JJ, Roosendaal CM, Kragt JJ, Eurelings M, van Genugten J, Nielsen J, Sinnige L, Kloosterziel ME, Arnoldus EP, van Dijk GW, Bouvy WH, Strijbis EM, van Oosten BW, de Jong BA, Uitdehaag BM, Rispens T, Killestein J, van Kempen ZL, Teunissen CE. Toorop AA, et al. Among authors: rispens t. Mult Scler. 2024 Nov;30(13):1683-1688. doi: 10.1177/13524585241293940. Epub 2024 Nov 4. Mult Scler. 2024. PMID: 39494701 Free PMC article.
Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID.
Kummer LYL, Fernández Blanco L, Kreher C, Bos A, Kuijper LH, Verstegen NJM, van de Sandt CE, Konijn VAL, Duurland MC, Menage C, Jorritsma T, Steenhuis M, Hagen RR, van den Dijssel J, de Jongh R, Ashhurst T, van Gils MJ, Garcia-Vallejo JJ, Claireaux M, Stalman EW, van Dam KPJ, Wieske L, Boekel L, Wolbink G, Tas SW, Rispens T, Kuijpers TW, Eftimov F, van Ham SM, Ten Brinke A; T2B! Immunity Against SARS-CoV-2 Study Group. Kummer LYL, et al. Among authors: rispens t. RMD Open. 2024 Oct 7;10(4):e004664. doi: 10.1136/rmdopen-2024-004664. RMD Open. 2024. PMID: 39375177 Free PMC article.
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases.
van Dam KPJ, Wieske L, Stalman EW, Kummer LYL, van der Kooi AJ, Raaphorst J, van de Beek D, Verschuuren JJGM, Ruiter AM, Brusse E, van Doorn PA, Baars AE, van der Pol WL, Goedee HS, Ten Brinke A, van Ham SM, Rispens T, Kuijpers TW, Eftimov F; T2B! Immunity Against SARS‐CoV‐2 Study Group. van Dam KPJ, et al. Among authors: rispens t. Eur J Neurol. 2024 Dec;31(12):e16409. doi: 10.1111/ene.16409. Epub 2024 Sep 5. Eur J Neurol. 2024. PMID: 39236312 Free PMC article.
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial.
Lend K, Lampa J, Padyukov L, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Rudin A, Østergaard M, Haavardsholm EA, Hørslev-Petersen K, Uhlig T, Sokka-Isler T, Gudbjornsson B, Grondal G, Frazzei G, Christiaans J, Wolbink G, Rispens T, Twisk JWR, van Vollenhoven RF. Lend K, et al. Among authors: rispens t. Ann Rheum Dis. 2024 Nov 14;83(12):1657-1665. doi: 10.1136/ard-2024-226024. Ann Rheum Dis. 2024. PMID: 39079894 Free PMC article. Clinical Trial.
Belimumab concentration measurements using a homologous anti-idiotype immunoassay.
Loeff FC, Parodis I, Walhelm T, Jönsen A, Nikolopoulos D, Sjöwall C, Bengtsson AA, Kos D, van Leeuwen A, van den Broek B, Dijk L, Jeremiasse J, Blomjous BS, Voskuyl AE, Wolbink GJ, Bultink IEM, Rispens T. Loeff FC, et al. Among authors: rispens t. J Immunol Methods. 2024 Sep;532:113717. doi: 10.1016/j.jim.2024.113717. Epub 2024 Jul 2. J Immunol Methods. 2024. PMID: 38960066
303 results